Recent Finacing
Recent Raise
SeptRx develops the Intrapocket PFO Occluder for percutaneous transcatheter patent foramen ovale closure, completed an 11‑patient first‑in‑human trial with three‑year follow‑up, and is initiating a European CE-mark trial.
Focus Areas
Recent Investors
Total Raised
Funding round
Investor